Tag: Impella

Quick Tips: Impella CP with SmartAssist™

Impella CP with SmartAssist™ Experience Inder Singh, MD, MS, interventional cardiologist at Dignity Heart & Vascular discusses the Impella CP with SmartAssistTM technology and his team’s experience during the limited market release. The latest innovation on the Impella platform integrates the trusted performance of the Impella CP heart pump with state-of-the-art SmartAssist™ technology. This next … Continue reading “Quick Tips: Impella CP with SmartAssist™”

Hub-Spoke Patient Transfer Packet

Use this patient transfer checklist and documentation when transferring a patient supported with an Impella® device  from the “Spoke” hospital to the “Hub” hospital. Completing the patient transfer checklist ensures the best possible outcome for the patient during the transfer process.

Impella® Device Support During High-Risk Unprotected Left Main Percutaneous Coronary Intervention Demonstrates Favorable Safety and Efficacy Outcomes

Reference: Schreiber T et al. Catheter Cardiovasc Interv. 2017;90(4):576-581. The use of prophylactic Impella® device support during unprotected left main (ULM) percutaneous coronary intervention (PCI) is safe and effective for improving hemodynamic variables in high-risk, non-cardiogenic shock (CS) patients, according to findings from a large, single-center, retrospective review of the USpella registry from Schreiber et … Continue reading “Impella® Device Support During High-Risk Unprotected Left Main Percutaneous Coronary Intervention Demonstrates Favorable Safety and Efficacy Outcomes”

Impella RP® Weaning Recommendations from Dr. Tim Larkin

Dr. Tim Larkin of Edward Hospital describes his weaning protocol for the Impella RP® during this physician Q&A session. In this session, Dr. Larkin explains the utility of the pulmonary artery pulsatility index for gauging appropriate weaning time for the Impella RP. Dr. Larkin also recommends monitoring serum lactate for assessing tissue perfusion prior to … Continue reading “Impella RP® Weaning Recommendations from Dr. Tim Larkin”

Dr. Thorsten Siess, Abiomed’s CTO and Inventor of Impella® Shares his Insights on the Impella® Platform of Devices

Dr. Thorsten Siess, Abiomed’s Chief Technology Officer and inventor of Impella® discusses how the world’s smallest heart pump transformed from a product to a platform. Listen in to learn how the Abiomed team is developing new features to satisfy the clinician community’s needs. What new features are being developed by Dr. Siess now? Press play … Continue reading “Dr. Thorsten Siess, Abiomed’s CTO and Inventor of Impella® Shares his Insights on the Impella® Platform of Devices”

IABP vs Impella®: Incidence of Bleeding and Vascular Complications

Key Takeaways Patients undergoing high-risk PCI often require additional hemodynamic support, particularly with the help of ventricular assist devices. There is no significant difference between Impella 2.5® and IABP in terms of bleeding risk and vascular complications. High-risk patients with acute coronary syndrome (ACS) often require additional cardiac support during a protected percutaneous coronary intervention … Continue reading “IABP vs Impella®: Incidence of Bleeding and Vascular Complications”

Patients Too Weak for Surgery May Benefit from Heart Pumps

High-risk heart disease patients who present major abnormalities may be too weak for open-heart surgery; however, the utilization of certain techniques and devices may circumvent such medical challenges. Patients too weak for surgery who undergo a percutaneous coronary intervention (PCI), for example, have been treated in conjunction with the placement of Impella® . One case … Continue reading “Patients Too Weak for Surgery May Benefit from Heart Pumps”

Percutaneous Insertion and Removal of Impella® Using the Axillary Artery for Treatment of Advanced Peripheral Artery Disease

Peripheral arterial disease (PAD), also referred to as hardening of the arteries, is a vascular disease that occurs in the arteries in the circulatory system. In PAD, the disease occurs in the arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. For interventions that are aimed toward treating PAD or providing mechanical support, common femoral and brachial arteries are typical access sites for devices such as Impella® or intraaortic balloon pumps. Radial access does present its fair share of limitations, despite it becoming an increasingly popular access method among interventionalists. This synopsis of a recent article from the Journal of Invasive Cardiology provides a brief overview of the percutaneous insertion and removal of the Impella device using the axillary artery.The technique for insertion and removal of the Impella device using the axillary artery (AA) is as follows: Continue readingPercutaneous Insertion and Removal of Impella® Using the Axillary Artery for Treatment of Advanced Peripheral Artery Disease